CONMED Corp — Director's Dealing 2022

Dec 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-12-09

Reporting Person: Garner Todd W (Executive Vice President & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-09	Common Stock	M	4500	$50.61	Acquired	4501	Direct
2022-12-09	Common Stock	S	4500	$89.31	Disposed	1	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-09	Options To Purchase Common Stock	$50.61	M	4500	Disposed	2028-01-02	Common Stock (4500)	Direct

Footnotes

F1: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan.

F2: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.